ClinicalTrials.govpublic full text
Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies
myeloid malignancies, allogeneic hematopoietic stem cell transplantation, acute graft-versus-host disease, unrelated donors, post-transplant cyclophosphamide, unrelated hematopoietic cell transplantation, gitmo, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 842733
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.